Development of compounds for multiple regulation of intracellular signaling
开发用于细胞内信号传导多重调节的化合物
基本信息
- 批准号:11470496
- 负责人:
- 金额:$ 4.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Many diseases are known to be caused by the disorder of intracellular signaling machinery. The disorder would be repaired by developing an appropriate means of manipulating the signaling system. Thus, we attempted to develop man-made molecules to keep well-balanced intracellular signaling environment related to acquired immune deficiency syndrome (AIDS).Expression of HIV-1 provirus is governed primarily by cellular transcription factors NFκB, HIV-EP1, and Sp1. Inhibition of the function of these transcriptional proteins would lead to the interference of the replication of AIDS virus. Herein we report our approach for the inhibition of NFκB, HIV-EP1, and Sp1.The function of zinc finger protein could be inhibited if we could obtain metal chelators that target the zinc site of these transcription factors. We designed imidazole-pyridine-imidazole systems and found that compounds are efficient zinc chelators exhibiting remarkable inhibitory effect on the DNA binding of HIV-EP1 and Sp1 at 300 μM concentration. We further designed sulfurcontaining ligands, cysteamine-pyridine-cysteamine system, and found those to be uniformly effective at 30 μM concentration against both HIV-EP1 and Sp1.. We have also serendipitously shown that some of imidazole-pyridine-imidazole compounds inhiited the DNA binding of NFκB at 300 μM concentration. Further, it was shown that aurine tricarboxylic acid is a potent inhibitor of NFκB-DNA bindinf effective at 30 μM concentration.
已知许多疾病是由细胞内信号机制的紊乱引起的。这种疾病可以通过开发适当的操纵信号系统的方法来修复。因此,我们试图开发人工分子来维持与获得性免疫缺陷综合征(AIDS)相关的细胞内信号环境的良好平衡。HIV-1前病毒的表达主要受细胞转录因子NFκB、HIV-EP 1和Sp1的调控。抑制这些转录蛋白的功能将导致艾滋病病毒复制的干扰。本文报道了抑制NFκB、HIV-EP 1和Sp1转录因子的方法。如果我们能够获得靶向这些转录因子锌位点的金属螯合剂,那么锌指蛋白的功能将被抑制。我们设计了咪唑-吡啶-咪唑体系,发现这些化合物是有效的锌螯合剂,在300 μM浓度下对HIV-EP 1和Sp1的DNA结合有显著的抑制作用。我们进一步设计了含硫配体,半胱胺-吡啶-半胱胺系统,并发现它们在30 μM浓度下对HIV-EP 1和Sp1都是均匀有效的。我们还意外地发现,一些咪唑-吡啶-咪唑化合物在300 μM浓度下抑制了NFκB的DNA结合。此外,研究表明,aurine tricarboxylic acid是一种有效的NFκB-DNA结合抑制剂,在30 μM浓度下有效。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Teruhiko Inoue: "Fluorescence property of oxazole yellow-linked oligonucleotide. Triple helix formation and photocleavage of double-stranded DNA"Bioorg.Med.Chem.. 7. 1207-1211 (1999)
Teruhiko Inoue:“恶唑黄连接寡核苷酸的荧光特性。双链 DNA 的三螺旋形成和光裂解”Bioorg.Med.Chem.. 7. 1207-1211 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masami Otsuka, Akiyuki Hamasaki, Hiromasa Kurosaki, Masafumi Goto: "Synthesis, Structure of Copper (II) Complexes of S-containing Pentadentate Ligands"J.Organomet.Chem.. 611. 577-585 (2000)
Masami Otsuka、Akiyuki Hamasaki、Hiromasa Kurosaki、Masafumi Goto:“含 S 五齿配体的铜 (II) 配合物的合成、结构”J.Organomet.Chem.. 611. 577-585 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Rakesh Kumar Sharma: "Aurine tricarboxylic acid, a potential metal-chelating inhibitor of NFκB-DNA binding"Bioorg.Med.Chem.. 8. 1819-1823 (2000)
Rakesh Kumar Sharma:“金三羧酸,NFκB-DNA 结合的潜在金属螯合抑制剂”Bioorg.Med.Chem.. 8. 1819-1823 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masami Otsuka: "Synthesis, structure of Cu (II) complexes of S-containing pentadentate ligands"J.Organomet.Chem.. 611. 577-585 (2000)
Masami Otsuka:“含S五齿配体的Cu(II)络合物的合成、结构”J.Organomet.Chem.. 611. 577-585 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Rakesh Kumar Sharma, Bhagwan Singh Garg, Hiromasa Kurosaki, Masafumi Goto, Masami Otsuka, Tadashi Yamamoto, Jun-ichiro Inoue: "Aurine Tricarboxylic Acid, a Potent Metal-Chelating Inhibitor of NF_B-DNA Binding"Bioorg.Med.Chem.. 8(7). 1819-1823 (2000)
Rakesh Kumar Sharma、Bhagwan Singh Garg、Hiromasa Kurosaki、Masafumi Goto、Masami Otsuka、Tadashi Yamamoto、Jun-ichiro Inoue:“金三羧酸,NF_B-DNA 结合的有效金属螯合抑制剂”Bioorg.Med.Chem.. 8
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OTSUKA Masami其他文献
OTSUKA Masami的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OTSUKA Masami', 18)}}的其他基金
Design and synthesis of anti-brain tumor and brain-protective drugs using brain-targeting peptides
脑靶向肽设计与合成抗脑肿瘤和脑保护药物
- 批准号:
24659048 - 财政年份:2012
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of medicinal molecules having biologically functions targeting the PI3K/Akt pathway and the TGF-b/Smad pathway
开发具有针对PI3K/Akt途径和TGF-b/Smad途径的生物学功能的药物分子
- 批准号:
23390028 - 财政年份:2011
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Design and synthesis of anti-HIV agents that inhibit the Vif-mediated proteasome degradation of APOBEC3G
设计和合成抑制 Vif 介导的 APOBEC3G 蛋白酶体降解的抗 HIV 药物
- 批准号:
22659024 - 财政年份:2010
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Design of DNA-cleaving and -crosslinking agents based on NFκB and HMGA proteins aiming at the application to cancer therapy
基于 NFκB 和 HMGA 的 DNA 切割和交联剂设计,针对蛋白质在癌症治疗中的应用
- 批准号:
20390033 - 财政年份:2008
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of zinc chelators with protein specificity aiming at molecular target therapy of cancer
开发针对癌症分子靶向治疗的蛋白质特异性锌螯合剂
- 批准号:
17390030 - 财政年份:2005
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular design of anti-AIDS drugs targeting the viral and host zinc proteins
针对病毒和宿主锌蛋白的抗艾滋病药物的分子设计
- 批准号:
15390038 - 财政年份:2003
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular design of anti-AIDS drugs targeting the human transcription machinery employed for the replication of AIDS virus
针对艾滋病病毒复制所用的人类转录机制的抗艾滋病药物的分子设计
- 批准号:
12557219 - 财政年份:2000
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Design of Ras Farnesyltransferase Inhibitors
Ras 法尼基转移酶抑制剂的分子设计
- 批准号:
11694297 - 财政年份:1999
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular design and synthesis of anti-cancer compounds that cause apoptosis
引起细胞凋亡的抗癌化合物的分子设计和合成
- 批准号:
09672280 - 财政年份:1997
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Identification of novel, interferon-inducible anti-AIDS virus host factors
新型干扰素诱导抗艾滋病病毒宿主因子的鉴定
- 批准号:
17K15701 - 财政年份:2017
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Investigation of the molecular mechanism of AIDS virus evolution
艾滋病病毒进化的分子机制研究
- 批准号:
15K07166 - 财政年份:2015
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Introducing restriction factors into the genome of an AIDS virus host species
将限制因子引入艾滋病病毒宿主物种的基因组中
- 批准号:
9025396 - 财政年份:2015
- 资助金额:
$ 4.22万 - 项目类别:
Studies of the precursor of the human AIDS virus in its natural chimpanzee host
对黑猩猩天然宿主中人类艾滋病病毒前体的研究
- 批准号:
9186500 - 财政年份:2015
- 资助金额:
$ 4.22万 - 项目类别:
Studies to search for the process from the birth of AIDS virus in the heart of African continent to its pandemic transmission route to the whole world
研究探寻艾滋病病毒从非洲大陆中心诞生到全球大流行传播途径的过程
- 批准号:
26257505 - 财政年份:2014
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
疫苗诱导的 CD8 T 细胞能否阻止慢性期艾滋病病毒复制?
- 批准号:
8787712 - 财政年份:2014
- 资助金额:
$ 4.22万 - 项目类别:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
疫苗诱导的 CD8 T 细胞能否阻止慢性期艾滋病病毒复制?
- 批准号:
8976140 - 财政年份:2014
- 资助金额:
$ 4.22万 - 项目类别:
Mechanism analysis of lasting of AIDS virus control with SIV controllers.
SIV控制剂持久控制艾滋病病毒的机制分析。
- 批准号:
25893294 - 财政年份:2013
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Introducing restriction factors into the genome of an AIDS virus host species
将限制因子引入艾滋病病毒宿主物种的基因组中
- 批准号:
8645612 - 财政年份:2012
- 资助金额:
$ 4.22万 - 项目类别:
Introducing restriction factors into the genome of an AIDS virus host species
将限制因子引入艾滋病病毒宿主物种的基因组中
- 批准号:
8464631 - 财政年份:2012
- 资助金额:
$ 4.22万 - 项目类别: